Brown Advisory’s Asensus Surgical, Inc. ASXC Stock Holding History

Brown Advisory’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,129	Closed	-$91K	–	1044
2019 Q2	$91K	Buy	+5,129	New	+$112K	﹤0.01%	1001

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Brown Advisory's ASXC Position: Q3 2019 in Review

Brown Advisory sold out of Asensus Surgical, Inc. (ASXC) in Q3 2019, closing a stake of 5,129 shares — an estimated $91K sold.

Brown Advisory first reported a position in ASXC in Q2 2019 and held it in 1 quarter. The position peaked at $91K in Q2 2019. 130 funds tracked by Wall St. Rank hold ASXC as of Q3 2019.

Brown Advisory reported no remaining Asensus Surgical, Inc. position as of Q3 2019 after selling out during the quarter.
Brown Advisory sold 5,129 Asensus Surgical, Inc. shares in Q3 2019, an estimated $91K.
Brown Advisory first reported a position in Asensus Surgical, Inc. in Q2 2019 and held it in 1 quarter.
Brown Advisory's Asensus Surgical, Inc. position peaked at $91K in Q2 2019.
130 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2019.

Based on Brown Advisory's 13F filing for Q3 2019, filed 14 Nov 2019.